Table 3.
Antiproliferative activity of GSLs hydrolyzed compounds (isothiocyanates, ITCs).
Compounds | Cell Lines/In Vivo Models | Activity | Reference |
---|---|---|---|
Benzyl-ITCs | HT29 colon carcinoma cells | Apoptosis induction | [90] |
BxPC-3 cells | Cell cycle arrest, apoptotic induction, inhibition of NF-κB | [91] | |
Hamsters | Protection against pancreatic carcinogenesis initiation | [92] | |
Caco-2 and LS-174 cells | Growth inhibition | [93] | |
HNSCC head and neck squamous cell carcinoma cell line | Activation of PARP cleavage and caspase-3 | [94] | |
Allyl-ITCs | Swiss albino mice | Inhibition of cyclophophamide-induced urotoxicity | [95] |
PC-3 xenografts | Growth inhibition | [96] | |
LNCaP cells | Apoptosis induction and growth inhibition by G2/M arrest | [97] | |
Human myeloblastic leukemia-1 cells | Inhibition of HL60 (p53-) and (p53þ) | [98] | |
4-Methylsulfinylbutyl-ITCs | Hamsters | Protective activity against pancreatic carcinogenesis initiation | [92] |
MDA-MB-231 cells | Growth inhibition | [89] | |
Mice | Benzo(a)pyrene-induced forestomach cancer inhibition | [99] | |
L-1210 and ME-18 cells | Growth inhibition and induction of apoptosis | [100] | |
HepG2 cells | Growth inhibition | [101] | |
PC-3 cells | Caspases-mediated apoptosis | [102] | |
Medulloblastoma cells | Caspases-mediated apoptosis | [103] | |
DU-145 cells | Growth inhibition | [104] | |
LNCaP cells | Growth inhibition | [93] | |
Human T-cell leukemia | Induction of apoptosis and cell cycle arrest | [105] | |
HT29 cells | Growth inhibition | [106] | |
F344 rats | Azoxymethane-induced colonic crypt foci inhibition | [107] | |
Phenylethyl-ITCs | F344 rats | Tumorigenicity and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct inhibition | [84] |
Rats | Azoxymethane-induced colonic crypt foci inhibition | [108] | |
DU-145 and LNCaP cells | Enhancement of p21 protein and G0–G1 arrest | [109] | |
F344 rats | Azoxymethane-induced colonic crypt foci inhibition | [107] | |
p53-deficient PC-3 cells | Apoptosis induction | [110] | |
LNCaP cells | Apoptosis induction | [111] | |
Rats | Urinary bladder tumorigenesis inhibition | [112] | |
HT29 cells | Caspase-3 activation and Inhibition of NF-κB activity | [113] | |
HL60 cells | Protein kinase C inhibition | [114] | |
Leukemia and human bladder carcinoma cells | Growth inhibition | [115] | |
Rats | 4-(Methylnitrosamino)-1(3-pyridyl)-1-butone-induced pulmonary neoplasia | [116] | |
Ovarian cancer cells | Apoptosis induction | [117] | |
7-Methylsulfinylheptyl-ITCs | MDA-MB-231 cells | Suppression of activity | [118] |
Indole ethyl-ITCs | SH-S454, SMS-KCNR, SK-N-SH, IMR-32 cells | Anti-proliferative and apoptotic effects | [119] |
Phenylmethyl-ITCs | HeLa cells | Caspase-3 activation | [120] |
Phenyl-ITCs | Swiss albino mice | Cyclophophamide-induced urotoxicity inhibition | [95] |
Phenylbenzyl-ITCs | HeLa cells | Caspase-3 activation | [120] |
Some portions of the table are reproduced from Vig et al. [121] with permission (originally Table 6).